[Occurrence of Malignant Peritoneal Mesothelioma 19 Years after Concurrent Chemoradiation Therapy for Uterine Cervical Cancer Stage ⅢB-A Case Report and Literature Review].

The patient was in her 50s, had received concurrent chemoradiotherapy for stage ⅢB cervical cancer approximately 19 years ago, and was in good health. She had an ileus 3 months earlier and underwent an experimental laparotomy 2 months before, which revealed cancerous peritonitis, as well as a biopsy of a tumor in the peritoneum. Histological examination revealed malignant peritoneal mesothelioma(MPM). The patient died 2 months postoperatively. Histological examination was the primary diagnostic method, supplemented by HE staining, immunostaining, and genetic testing, for establishing MPM diagnosis. MPM is an extremely rare secondary cancer following cervical cancer treatment.